Gnas Inactivation In Heterotopic Ossification

Loading...
Thumbnail Image
Degree type
Doctor of Philosophy (PhD)
Graduate group
Cell & Molecular Biology
Discipline
Subject
adipose tissue
Gnas
heterotopic ossfication
progressive osseous heteroplasia
Cell Biology
Funder
Grant number
License
Copyright date
2021-08-31T20:21:00-07:00
Distributor
Related resources
Author
Brewer, Niambi
Contributor
Abstract

Heterotopic ossification (HO), the formation of bone outside of the skeleton, occurs in response to severe trauma and in rare genetic diseases such as progressive osseous heteroplasia (POH). In POH, which is caused by inactivation of GNAS, a gene that encodes the alpha stimulatory subunit of G proteins (Gαs), HO typically initiates within subcutaneous soft tissues before progressing to deeper connective tissues. To mimic POH, we used conditional Gnas-null mice which form HO in subcutaneous tissues upon Gnas inactivation. In response to Gnas inactivation, we determined that prior to detection of heterotopic bone, dermal adipose tissue changed dramatically, with progressively decreased adipose tissue volume and increased density of extracellular matrix over time. Upon depletion of the adipose tissue, heterotopic bone progressively formed in those locations. Through implant studies of adipose stromal cells, we found that mutant cells in a Gnas-null tissue environment induced a robust HO response while little/no HO was detected in control hosts. Additionally, a Gnas-null tissue environment appeared to support the recruitment of control cells to heterotopic bone, although control cell implants were associated with less HO formation compared to mutant cells. Our data support that Gnas inactivation alters the tissue microenvironment to influence mutant and wild-type progenitor cells to contribute to HO formation. Simultaneously, Gnas inactivation in ASCs leads to a potential misinterpretation of soft substrates, which can influence the osteogenic phenotype. While POH is a rare genetic disorder, this model helps to also provide an understanding of the processes of non-genetic HO and can inform us of potential targets for intervention and preventative therapeutics.

Advisor
Eileen M. Shore
Date of degree
2021-01-01
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Volume number
Issue number
Publisher
Publisher DOI
Journal Issue
Comments
Recommended citation